Bayer Corp. has agreed to pay $40 million to resolve alleged violations under the False Claims Act related to three drugs, the U.S. Justice Department said Friday.
It was alleged that the company used kickbacks and false statements in connection with the drugs Trasylol, Avelox and Baycol. The settlement follows two whistleblower lawsuits filed by Laurie Simpson, a former employee of Bayer who worked in its marketing department.
Under the terms of the settlement, Bayer and its related entities--Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC and Bayer AG--will pay roughly $38.9 million to the U.S. and more than $1.1 million to 20 states and the District of Columbia.
A Bayer spokesman said that the allegations focus on conduct that dates back more than 15 years.
"The settlement of these cases, which does not include any admission of wrongdoing, reflects a business decision by the company that resolution was preferable to continuing already protracted litigation under a statute that is inefficient and in need of reform," spokesman Christopher Loder said.
Mr. Loder also said that, as a result of the settlement, the two cases made under the False Claims Act would be dismissed.
Under the first lawsuit, Ms. Simpson alleged that the company paid kickbacks to hospitals and physicians to get them to use the drugs Trasylol and Avelox. She also alleged that the drugs were marketed for off-label uses that were not reasonable or necessary, and that Bayer downplayed the...
Who: Plaintiff John Gay filed a class action lawsuit against SeaWorld Parks & Entertainment Inc. Why: Gay claims SeaWorld sent emails that contained misleading subject lines to Washington r...